WHO advises against Gilead's remdesivir for all hospitalised COVID-19 patients
Gilead’s drug remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence it improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday.
View the full story here: https://www.reuters.com/article/us-health-coronavirus-remdesivir-who-idUSKBN28000Q